Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Inverse electron demand Diels–Alder reaction (IEDDA) is a synthetic organic chemistry reaction involving a cycloaddition between an electron-poor diene (often tetrazine) and an electron-rich dienophile (often a strained alkene such as trans-cyclooctene). The IEDDA is renowned for its rapid kinetics, irreversible nature due to nitrogen release, catalyst-free conditions, and excellent chemical selectivity, making it ideal for applications in bioorthogonal chemistry—reactions that occur specifically in biological environments without interfering with native biochemistry. Typical applications include: Live-cell and animal imaging via site-specific labeling, Drug delivery and activation, Metabolic glycoengineering, Controlled protein or small molecule activation ("decaging"), and synthesis of biomaterials. IEDDA is not a biological macromolecule, nor is it a receptor, enzyme, or traditional drug target. Rather, it is a chemistry platform/tool enabling manipulation of biological molecules for research, diagnostics, and therapy.
Bioorthogonal cleavage: IEDDA enables rapid, catalyst-free covalent bond formation between a tetrazine (electron-poor diene) and a strained alkene (electron-rich dienophile), sometimes allowing removal ("decaging") or activation of a functional group on a biomolecule. Molecular imaging and probe generation: click-to-label or activate fluorescent reporters or drugs for cell/animal imaging.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Inverse electron demand Diels–Alder reaction (IEDDA).